Investing Profile
Michael Gladstone
Your Intro Paths to Michael Gladstone
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Michael is a member of
Harvard University Network
253 CONNECTIONS
L.E.K. Consulting Network
11 CONNECTIONS
Find Michael Gladstone on
cbCurrent Investing Position
Atlas Venture Partner
Investment Range
$10.0M - $50.0M
Sweet Spot
$25.0M
Investments On Record
13
Michael Gladstone is on these Sector & Stage Rankings
Michael Gladstone's Investments On Record (8)
Company | StageDateRound Size | Total Raised |
---|---|---|
Pheon Therapeutics | Series BMay 2024$120M Series ASep 2022$68M | $190M |
Diagonal Therapeutics | Series AApr 2024$130M | $130M |
SAPI | UndisclosedMar 2023 | $10M |
Versanis Bio | Series AAug 2021$70M | $70M |
Day One Biopharmaceuticals | Series BFeb 2021$130M Series AMay 2020$60M | $370M |
Third Harmonic Bio | Series AJan 2019$50M | $50M |
Spero Therapeutics | Series BFeb 2016$30M Series AJun 2015$30M Series AApr 2014$3M SeedDec 2013 | $120M |
Surface Oncology | Series AJan 2015$35M | $35M |
Michael Gladstone's Experience
Partner Atlas Venture2020 - Present
Principal Atlas Venture2015 - Present
Associate Atlas Venture2012 - 2014
Senior Associate Consultant L.E.K. Consulting2009 - 2012
MLSC Fellow Eutropics Pharmaceuticals2009 - 2009
Michael Gladstone's Education
Harvard University BA Biochemical Sciences
Investors who invest with Michael Gladstone